Here is What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Flexion Therapeutics Inc (FLXN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.75 | 2,051 | Director | 2,051 | 2020-05-26 | Filing | |
| $9.75 | 10,256 | Officer, Director | 346,605 | 2020-05-26 | Filing | |
| $10.74 | 2,000 | Large Shareholder, Director | 45,333 | 2019-08-08 | Filing | |
| $10.85 | 2,317 | Officer, Director | 72,249 | 2019-08-08 | Filing | |
| $11.05 | 2,500 | Officer | 89,424 | 2019-05-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.45 | 3,945 | Officer | 141,241 | 2021-07-19 | Filing | |
| $6.45 | 3,944 | Officer | 140,362 | 2021-07-19 | Filing | |
| $6.45 | 1,870 | Officer | 103,666 | 2021-07-19 | Filing | |
| $6.45 | 3,945 | Officer | 133,486 | 2021-07-19 | Filing | |
| $7.23 | 2,229 | Officer | 220,719 | 2021-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is FLXN A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Flexion Therapeutics Inc (NASDAQ:FLXN) is a good investment right now.
Why Flexion Therapeutics (FLXN) Stock is a Compelling Investment Case
Miller Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here.
Here's What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)
In this article you are going to find out whether hedge funds think Flexion Therapeutics Inc (NASDAQ:FLXN) is a good investment right now.
Is Flexion Therapeutics (FLXN) a Smart Long-term Buy?
Miller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download here.
Should You Buy Flexion Therapeutics Inc (FLXN)?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is Flexion Therapeutics Inc (FLXN) A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Here's What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Here's What Hedge Funds Think About Flexion Therapeutics Inc (FLXN)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their...
Chevron, Conduent, Flexion, and More: Stocks in the Spotlight
The spotlight is on Uber today as the company makes its stock market debut on Friday.